Status | Study |
Terminated |
Study Name: Vitamin D Supplementation in Polymorphic Light Eruption Condition: Polymorphic Light Eruption Date: 2012-04-26 Interventions: Drug: Oral Vitamin D 3 40,000 |
Completed |
Study Name: Fluoride Varnish for Treatment of White Spot Lesions Condition: White Spot Lesions Date: 2011-12-22 Interventions: Device: Vanish varnish 5% sodi |
Completed |
Study Name: Remineralisation of White Spot Lesions by Elmex® gelée in Post-orthodontic Patients Condition: Tooth; Lesion, White Spot Lesions Date: 2011-04-01 Interventions: Drug: elmex® gelée 1 |
Active, not recruiting |
Study Name: FOLFIRI in Combination With Cetuximab in the First-line Treatment of Metastatic Colorectal Cancer Including a Regular Dermal Prophylaxis to Prevent Acneiforme Follicular Exanthema Condition: Colorectal Cancer Metastatic Date: 2011-03-11 Interventions: Drug: FOLFIRI + Cetuximab |
Withdrawn |
Study Name: Study of Acitretin to Treat Skin Rash Caused by Erlotinib (a Chemotherapy Drug) Condition: Skin Rash Date: 2011-02-15 Interventions: Drug: Acitretin Acitretin 10 mg by mouth daily Other |
Completed |
Study Name: Evaluating Preventive Therapy With Oint Threolone, Synthomycine or Aqua Cream, for EGFR'I Induced Acneiform Rash Condition: Acneiform Rash Date: 2010-12-07 Interventions: Drug: Threolone ointment ointm |
Withdrawn |
Study Name: Determination of Safety and Consumers' Satisfaction of Moussik Versus Desitin Creamy Ointment in Diaper Rash Prophylaxis Condition: Diaper Rash Date: 2010-07-20 Interventions: Other: Moussik Diaper Rash Mousse |
Completed |
Study Name: Calcipotriol and Polymorphic Light Eruption Condition: Polymorphic Light Eruption Date: 2009-03-27 Interventions: Drug: Calcipotriol-containing cream Topical treatment twice a day for 7 days |
Completed |
Study Name: Histological Characterization and Differentiation of Rash From Other Epidermal Growth Factor Receptor (EGFR) Inhibitors Condition: Skin Rash Date: 2008-07-01 Interventions: Procedure: Skin Biopsy of Skin Rash Secondary to EGFRI Use Patients who were treated with lapatinib, cet |
Active, not recruiting |
Study Name: Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash Condition: EGFR Inhibitor-associated Rash Date: 2008-04-07 Interventions: Drug: Menadione Topical Lotion |